Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.

Clinical trial NCT00313911 · COMPLETED

Trial details

NCT number: NCT00313911
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diphtheria Tetanus Pertussis Haemophilus Influenzae Type b Hepatitis B

Start date: 2006-07-01
Primary completion: 2008-01-01
Enrollment: 2133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.